Artwork

Content provided by Pharma Manufacturing. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pharma Manufacturing or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

FDA approves Adaptimmune therapy, halts vTv diabetes program; Sanofi sues Sarepta over Duchenne patents [The good, the bad, the ugly]

3:58
 
Share
 

Manage episode 432693878 series 2941835
Content provided by Pharma Manufacturing. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pharma Manufacturing or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:

The good — FDA approves Adaptimmune engineered cell therapy
The bad — FDA puts clinical hold on vTv Therapeutics diabetes program
The ugly — Sanofi sues Sarepta over manufacturing patents for Duchenne gene therapy

  continue reading

83 episodes

Artwork
iconShare
 
Manage episode 432693878 series 2941835
Content provided by Pharma Manufacturing. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pharma Manufacturing or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:

The good — FDA approves Adaptimmune engineered cell therapy
The bad — FDA puts clinical hold on vTv Therapeutics diabetes program
The ugly — Sanofi sues Sarepta over manufacturing patents for Duchenne gene therapy

  continue reading

83 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play